Skip to content

Clinical trials

Phase 2/3 Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Phase: Phase 2/3 Clear all

100 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20032
20041
20054
20064
20072
20082
20093
20102
20114
20123
20133
20147
20155
20162
20174
20186
20191
20213
20224
202311
20244
202512
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed37
Recruiting23
Unknown status19
Terminated10
Active, not recruiting5
Not yet recruiting4
Withdrawn1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cancer Research UK8
Monash University5
M.D. Anderson Cancer Center4
Ain Shams University3
AbbVie2
Amgen2
Ann & Robert H Lurie Children's Hospital of Chicago2
ASLAN Pharmaceuticals1
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
Alexandria University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms100
Fatigue9
Hematologic Neoplasms8
Leukemia8
Lymphoma8
Neoplasms by Site8
Neoplasms by Histologic Type7
Carcinoma, Non-Small-Cell Lung6
Colorectal Neoplasms6
Neoplasm Metastasis6

Trials

Showing 26 to 50 of 100. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.